Mehdi Javanmard receives DARPA ElectRx Program Grant

Professor Mehdi Javanmard is the recipient of a DARPA award for the project titled "The Proteomic Smartpatch Phase IB: Transcutaneous Monitoring of Molecular Biomarkers in Blood Using Flexible and Natural Substrates." This is a six month $200,000 collaborative effort between Rutgers University (Mehdi Javanmard, PI) and University of Pennsylvania (Mark Allen, Co-PI). Rutgers' share for this award is $100,000.

As part of this project, Mehdi and his team will continue development of a wearable biosensing platform whose purpose is to continuously monitor biomarkers of inflammation in the bloodstream in response to stimulation of the peripheral nervous system for treatment of chronic inflammatory diseases. This project is part of DARPA's effort to fulfill the vision of the Agency’s Electrical Prescriptions (ElectRx) program, which has as its goal the development of a closed-loop system that treats diseases by modulating the activity of peripheral nerves. The teams will initially pursue a diverse array of research and technological breakthroughs in support of the program’s technical goals. Ultimately, the program envisions a complete system that can be tested in human clinical trials aimed at conditions such as chronic pain, inflammatory disease, post-traumatic stress and other illnesses that may not be responsive to traditional treatments.

Congratulations, Mehdi!